Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2020 Dec 15;173(12):964-973.
doi: 10.7326/M20-3569. Epub 2020 Sep 4.

Attitudes Toward a Potential SARS-CoV-2 Vaccine : A Survey of U.S. Adults

Kimberly A Fisher  1 , Sarah J Bloomstone  2 , Jeremy Walder  3 , Sybil Crawford  1 , Hassan Fouayzi  2 , Kathleen M Mazor  1
Affiliations
Multicenter Study

Attitudes Toward a Potential SARS-CoV-2 Vaccine : A Survey of U.S. Adults

Kimberly A Fisher et al. Ann Intern Med. .

Abstract

Background: Coronavirus disease 2019 (COVID-19) has rapidly instigated a global pandemic. Vaccine development is proceeding at an unprecedented pace. Once available, it will be important to maximize vaccine uptake and coverage.

Objective: To assess intent to be vaccinated against COVID-19 among a representative sample of adults in the United States and identify predictors of and reasons for vaccine hesitancy.

Design: Cross-sectional survey, fielded from 16 through 20 April 2020.

Setting: Representative sample of adults residing in the United States.

Participants: Approximately 1000 adults drawn from the AmeriSpeak probability-based research panel, covering approximately 97% of the U.S. household population.

Measurements: Intent to be vaccinated against COVID-19 was measured with the question, "When a vaccine for the coronavirus becomes available, will you get vaccinated?" Response options were "yes," "no," and "not sure." Participants who responded "no" or "not sure" were asked to provide a reason.

Results: A total of 991 AmeriSpeak panel members responded. Overall, 57.6% of participants (n = 571) intended to be vaccinated, 31.6% (n = 313) were not sure, and 10.8% (n = 107) did not intend to be vaccinated. Factors independently associated with vaccine hesitancy (a response of "no" or "not sure") included younger age, Black race, lower educational attainment, and not having received the influenza vaccine in the prior year. Reasons for vaccine hesitancy included vaccine-specific concerns, a need for more information, antivaccine attitudes or beliefs, and a lack of trust.

Limitations: Participants' intent to be vaccinated was explored before a vaccine was available and when the pandemic was affecting a narrower swath of the United States. Questions about specific information or factors that might increase vaccination acceptance were not included. The survey response rate was 16.1%.

Conclusion: This national survey, conducted during the coronavirus pandemic, revealed that approximately 3 in 10 adults were not sure they would accept vaccination and 1 in 10 did not intend to be vaccinated against COVID-19. Targeted and multipronged efforts will be needed to increase acceptance of a COVID-19 vaccine when one becomes available.

Primary funding source: Agency for Healthcare Research and Quality.

PubMed Disclaimer

Conflict of interest statement

Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M20-3569.

Figures

Visual Abstract.
Visual Abstract.. Attitudes Toward a Potential SARS CoV-2 Vaccine Among U.S. Adults
Once a vaccine for coronavirus disease 2019 becomes available, it will be important to maximize vaccine uptake and coverage. This national survey explores factors associated with vaccine hesitancy. The results suggest that multipronged efforts will be needed to increase acceptance of a coronavirus disease 2019 vaccine.
See this image and copyright information in PMC

Comment in

References

    1. World Health Organization. Coronavirus disease (COVID-19): situation report 106. World Health Organization; 2020. Accessed at www.who.int/docs/default-source/coronaviruse/situation-reports/20200505c... on 9 May 2020.
    1. Nicola M, Alsafi Z, Sohrabi C, et al. The socio-economic implications of the coronavirus pandemic (COVID-19): a review. Int J Surg. 2020;78:185-93. [PMID: 32305533] doi:10.1016/j.ijsu.2020.04.018 - PMC - PubMed
    1. Phua J, Weng L, Ling L, et al; Asian Critical Care Clinical Trials Group. Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations. Lancet Respir Med. 2020;8:506-17. [PMID: 32272080] doi:10.1016/S2213-2600(20)30161-2 - PMC - PubMed
    1. Ipsos. What worries the world. April 2020. Accessed at www.ipsos.com/sites/default/files/ct/news/documents/2020-04/what-worries... on 7 May 2020.
    1. Ipsos. Topline & methodology. 2020. Accessed at www.ipsos.com/sites/default/files/ipsos-coronavirus-us-aggregate-topline... on 9 May 2020

Publication types

Substances